CROI 2024 Program Guide

Poster Sessions

Poster Session-F3 | Long-Acting Injectables, Broadly Neutralizing Antibodies, and New Drugs, Oh My! 2:30 PM - 4:00 PM • Poster Hall C-D

Preclinical to Human Scaling of Pharmacokinetics for Long Acting Injectable Antiretrovirals Henry Pertinez , Rajith Rajoli, Andrew Lloyd, Joanne Sharp, Joanne Herriott, Edyta Kijak, Eduardo Gallardo-Toledo, Megan Neary, Helen Cox, Chloe Bramwell, Anthony Valentijn, Usman Arshad, Paul Curley, Charles W Flexner, Andrew Owen Pharmacokinetics of Long-Acting Cabotegravir and Rilpivirine in Elderly Using PBPK Modelling Sara Bettonte , Mattia Berton, Felix Stader, Manuel Battegay, Catia Marzolini Model-Based Comparison of Cabotegravir Pharmacokinetics Following Thigh and Gluteal Injections Kelong Han, Ronald D’Amico, William Spreen, Susan Ford Effect of Broadly Neutralizing Antibody Exposure on HIV Rebound Following Combination Immunotherapy Amelia N. Deitchman , Leonid Serebryannyy, Rowena Johnston, Lucio Gama, Marina Caskey, Elena Vendrame, Devi SenGupta, Romas Geleziunas, Jackie Reeves, Christos Petropoulos, Michel Nussenzweig, Rachel Rutishauser, Steven G Deeks, Michael J Peluso, for the UCSF amfAR Study Team A Randomized, Adaptive Phase I Study to Determine the Phase II Dose of VIR-7832: AGILE CST5 Richard J. FitzGerald , Chris Edwards, Jimstan Periselneris, Geoff Saunders, Nicky Downs, Rebecca Lyon, Danny Pratt, Helen Reynolds, Lauren Walker, Gareth Griffiths, Saye Khoo, Thomas Fletcher, for AGILE CST5 Discovery of Next-Generation CD4 Mimetic-Based Long-Acting Entry Inhibitors Wei Li, Margaret G Hines, Xiaojie Chu, Tianjian Liang, Cory Shetler, Kerri Penrose, Zhiwei Feng, Urvi M Parikh, Jana L. Jacobs , John W Mellors The Preclinical Profile of Maturation Inhibitor VH3739937 Brian McAuliffe , Paul Falk, Ira Dicker, Susan Jenkins, Jean Simmermacher, Mark Krystal Next-Generation Maturation Inhibitor GSK3640254 Showed Broad Spectrum Potency Without MI Resistance Jerry L. Jeffrey , Tom White, Samit Joshi, Brian Wynne Structure-Guided Optimization of InSTIs to Increase Antiviral Potencies Against HIV-1 IN Mutants Steven Smith , Xue Zhi Zhao, Stephen Hughes, Terrence R Burke Poster Session-G2 | Novel Antiretrovirals Development: More Than You Think! 2:30 PM - 4:00 PM • Poster Hall C-D

615

616 NIS

617

618

Poster Sessions • Wednesday

619

632

633

634

635

CROI 2024 157

New Investigator Scholarship

LB

NIS

Late-Breaking